BioHealth News Archive
NATIONAL BIOECONOMY BLUEPRINT
“The world is shifting to an innovation economy and nobody does innovation better than America.” —President Obama, December 6, 2011 Economic activity that is…
Read More
Drug research: All together now | The Economist
IT WAS once only drug firms that developed drugs. But this is changing. Take the case of the Michael J. Fox Foundation, a Parkinson’s…
Read More
Nodality loses leader to NEA as medical diagnostics model morphs – San Francisco Business Times
Growing diagnostic test developer Nodality Inc. is losing its first CEO, but the venture capital world is gaining another experienced life sciences entrepreneur. Dr.…
Read More
Zyngenia, Inc. Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in oncology and immunology, announced today that it has appointed David Parkinson, M.D.…
Read More
University of Maryland BioPark Announces MedImmune’s Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
BALTIMORE, MARYLAND, April 24, 2012 – The University of Maryland BioPark announced today thatBahija Jallal, Ph.D., Executive Vice President of Research and Development at…
Read More
Human Genome Sciences cuts losses – Washington Business Journal
Rockville-based Human Genome Sciences Inc., which last week rejected an unsolicited $2.6 billion acquisition offer by GlaxoSmithKline PLC, reported higher revenue and cut losses…
Read More
Maryland 12th in Venture Capital Dollars in First Quarter
Venture capital dollars flowing to Maryland companies were down almost 30 percent last quarter compared to a year ago, and 16 percent less than…
Read MoreMaryland Establishes New Tech Transfer Fund
The state and five universities are spending upwards of $5.8 million to help startups move from a concept to a company. Senate Bill 239/House Bill 442…
Read More
Genome entrepreneurs say their data will help you live longer | VentureBeat
The cost of sequencing the human genome continues to fall, reaching a low of $1,000 this year due to a new microchip and machine…
Read More
Supernus Pharmaceuticals readies D.C. region’s first biotech IPO since 2007 – Washington Business Journal
Supernus Pharmaceuticals Inc. is slated to go public this week, more than a year after first filing paperwork to list its stock on the…
Read More
Nabi Biopharmaceuticals to merge with Australian company – Baltimore Business Journal
Nabi Biopharmaceuticals, which began exploring strategic alternatives after failed late-stage clinical trials of its experimental smoking cessation vaccine, plans to merge with Australia's Biota…
Read More
What Are the Hottest Targets in Biotech Today? | Xconomy
Hardly anybody wants new drugs that act like a sledgehammer, bashing diseased and healthy cells like old-school cancer chemotherapy. Many drugs today are supposed to…
Read More
Top US colleges to offer online courses – Funded by NEA
Five prestigious US universities will create free online courses for students worldwide through a new, interactive education platform dubbed Coursera, the founders announced. The…
Read More
Johns Hopkins tops the list for expenditures in research & development
High-profile research institutions, many of which are members of Association of American Universities, provide many benefits for undergraduates on the fast-track to professional or…
Read More
14th Annual NIH SBIR/STTR Conference
In FY2012, there is now $717M available thanks to the increased SBIR/STTR set-asides afforded to us in the SBIR/STTR Reauthorization. The amount available will…
Read More